Search Tag: Dr. Carol Gallagher

Executive Health Management

2023 23 Jun

Mirati Therapeutics, Inc.®, a commercial stage biotechnology company announced its Board of Directors has appointed a new independent director, Dr. Carol Gallagher. "I am pleased to welcome Dr. Gallagher to our Board during this pivotal time for the company," said David Meek, chief executive officer, Mirati Therapeutics, Inc. "Carol brings a...Read more